This case is a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. The clinical pattern has been preserved.
He mentioned his father's skin in the third visit, almost as an apology for taking up time.
"Dry skin. Not arthritis. Unrelated."
He said the last word quickly, the way people do when they've already decided something doesn't count.
His own diagnosis was psoriatic arthritis. He'd received it in his mid-thirties, and it was correct. A rheumatologist had made it carefully and started a biologic. He took it exactly as prescribed.
I want to be clear about that part before anything else.
Nothing about his diagnosis was wrong. Psoriatic arthritis is a real inflammatory disease that can damage joints permanently. Biologic medicines changed what that disease does to people. That's evidence doing exactly what it should.
So this is not an essay about a missed diagnosis.
It's about what a correct one could not explain.
He came to me because the flares were getting worse. Eighteen months of rising disease activity, on a medication he took perfectly. His rheumatologist had suggested stress management.
He heard what most patients hear in that sentence. The problem is you.
I understood why the advice was given. I also understood why it landed badly. It pointed at something real and then left him alone with it.
Here's what the guidelines say to do when psoriatic arthritis stays active on a biologic. The 2023 European recommendations set the target as remission or low disease activity, with regular reassessment and adjustment. If a patient doesn't respond adequately, switching to another agent should be considered. The same recommendations tell clinicians to weigh comorbidities like obesity, metabolic syndrome, cardiovascular disease, and depression.
That is the population answer, and it's a good one. That conversation belonged with his rheumatologist, and nothing I did replaced it.
But the guideline could not know what I learned in the third visit.
When I asked whether anyone in his family had inflammatory or autoimmune problems, he mentioned the psoriasis. Then he paused. Then he mentioned an uncle with rheumatoid arthritis. The uncle had kept working with hands that slowly bent out of shape, and had called it nothing.
Nobody had ever put those men in the same sentence as his diagnosis.
Some of that is plain biology. Psoriatic disease runs in families. In one study of the families of 100 people with psoriatic arthritis, 7.6 percent of their parents, siblings and children had the arthritis too. That's about 30 times the rate you'd expect in the general population. Another 15 percent had psoriasis. His father's "dry skin" wasn't unrelated. It was part of his history, and it belonged in his chart.
The rest of the pattern was harder to name.
His father came to this country at twenty-two with tools and a conviction that a man who stopped was a man who failed. He built a small construction business over twenty-five years. For almost two of those years, he ran a fever and told no one but his wife. He kept working. The fever eventually went away, and nobody ever learned what it had been.
His son grew up inside that example. Nobody had to say the rule out loud.
You don't stop.
I asked him a question I ask a lot of people who are running on that rule. When did the work stop feeling like something you were doing and start feeling like something that was doing you?
The question opened a story he hadn't connected to his joints. Two years earlier, his company had been acquired. His hours hadn't exploded. What changed was quieter. The meaning of the work had been replaced by someone else's metrics. He kept performing at the same level. Then his flares began to climb.
Now I have to be careful, because this is exactly where wellness writing goes wrong.
Nothing here says stress gave him psoriatic arthritis. His genes and his immune system did that. I can't prove the acquisition caused a single flare. Nobody can prove that from one life.
What the evidence does support is narrower. In a large 2026 survey of people with psoriasis, stress was the trigger reported most often, by just over half of them. That's self-report, and it's about the skin disease, not the arthritis. Laboratory work points toward one possible mechanism. In a 2012 study, people living with a long-term threatening stressor had immune cells that responded less to cortisol's anti-inflammatory signal, and that reduced sensitivity predicted more inflammatory output after exposure to a cold virus. That was a cold model, not autoimmune disease. It's a direction, not a verdict.
Sleep is on firmer ground. A 2016 meta-analysis of 72 studies and more than 50,000 people linked disturbed sleep with higher levels of two inflammatory markers, CRP and IL-6. His sleep had been poor for a long time, and he called it normal.
So the clinical question changed.
It was no longer only whether the diagnosis was right. It was. The better question was what, in this particular life, kept supplying the fire the medication was trying to put out.
The better question was what, in this particular life, kept supplying the fire the medication was trying to put out.
We didn't tell him to work less in some vague way. He had a family and a business. We started with sleep, because it was measurable and because he could protect it. We talked about the work question honestly, without pretending he could walk away from it. And he kept every appointment with his rheumatologist.
Over about eight months, his flares came less often and hurt less when they came. I can't separate what the sleep did from what time did, or from what the medication was doing all along. I won't pretend otherwise.
What I can tell you is what changed in how he read them.
He stopped treating a flare as proof that his body was a defective tool. He started treating it as information about what the week had cost.
One afternoon he mentioned, almost in passing, that his teenage son had woken up sick. He'd told him, "Take the day. The work will wait."
He said it like a scheduling detail. His face said something else.
The diagnosis was correct from the beginning. It named his disease. It told his doctors which medicine to use, and that medicine protected his joints.
It just hadn't met his father yet.
I write Healing the Split for people whose diagnosis is right and whose recovery still feels incomplete. Subscribing is free, and it's how the next essay finds you.
If someone you love has a correct diagnosis and an unfinished story, send this to them.
What did no one ask you when you got your diagnosis? Tell me in the comments. I read them.
This essay uses a composite drawn from clinical encounters over many years. Names, ages, occupations, timelines, and identifying circumstances have been changed. No individual patient is depicted. It is not medical advice. If your condition is active on treatment, bring that to the clinician managing it.
Sources: Gossec L, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the Rheumatic Diseases, 2024. Chandran V, et al. Familial aggregation of psoriatic arthritis. Annals of the Rheumatic Diseases, 2009. PSODEEP1 study: psoriasis triggers and disease activity, Acta Dermato-Venereologica, 2026. Cohen S, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. PNAS, 2012. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation. Biological Psychiatry, 2016.
Dr Shiv Kumar Goel is an internal medicine and functional medicine physician and founder of Prime Vitality Care in San Antonio. Across 25 years in hospitals, intensive care, and functional medicine, he has studied the gap between what medicine can measure and what patients actually live through. He writes Healing the Split and is the author of the forthcoming book The Unread Life.